Trial intelligence / Profile preview

Gum and Metoclopramide for Post-operative Ileus

NCT05669781Phase 4Completed

Start
Oct 2018
Primary completion
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of metoclopramide in postoperative ileus (POI) (4 arms). Primary endpoint: Duration of post-operative ileus up to 1 week. Started Oct 2018; status: completed.

02

Drugs

metoclopramide
03

Conditions

postoperative ileus (POI)

Beyond the preview

Go deeper on NCT05669781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05669781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call